Aurinia Pharmaceuticals Inc. (FRA:IKAP)
12.91
+0.32 (2.58%)
Last updated: Dec 5, 2025, 8:04 AM CET
Aurinia Pharmaceuticals Employees
Aurinia Pharmaceuticals had 130 employees as of December 31, 2024. The number of employees decreased by 170 or -56.67% compared to the previous year.
Employees
130
Change (1Y)
-170
Growth (1Y)
-56.67%
Revenue / Employee
€1,742,678
Profits / Employee
€510,311
Market Cap
1.73B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 318,000 |
| Allianz SE | 156,626 |
| Deutsche Telekom AG | 198,194 |
| Siemens Energy AG | 103,000 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Rheinmetall AG | 28,539 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Aurinia Pharmaceuticals News
- 2 days ago - AUPH Sees Downgrade by Leerink Partners as Price Target is Raised | AUPH Stock News - GuruFocus
- 3 days ago - Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - The Motley Fool
- 3 days ago - Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - Nasdaq
- 11 days ago - First Week of AUPH July 2026 Options Trading - Nasdaq
- 23 days ago - FDA Appointment Boosts Aurinia Pharma (AUPH) and Biotech Stocks - GuruFocus
- 4 weeks ago - Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - Nasdaq
- 4 weeks ago - Jefferies Upgrades Aurinia Pharmaceuticals (AUPH) to Buy, Raises Price Target | AUPH Stock News - GuruFocus
- 4 weeks ago - AUPH: RBC Capital Downgrades Aurinia Pharmaceuticals, Raises Price Target | AUPH Stock News - GuruFocus